Guardant Health stock target raised to $55 by BTIG
BTIG raised the price target for Guardant Health (NASDAQ:GH) to $55.00, up from the previous target of $50.00, while maintaining a Buy rating on the stock. The adjustment came as Guardant Health shares soared by 15% in the morning following the announcement that Medicare coverage has been granted for its Guardant Reveal MRD test in the surveillance monitoring setting,